Chemical Compound
3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic Acid; Benzoic acid, 3-[[[3-[4-[(methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]-; 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]benzoic acid; 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)met
CAS Registry Number
1005334-57-5
Primary record
3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic Acid; Benzoic acid, 3-[[[3-[4-[(methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]-; 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]benzoic acid; 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)met
- 库存
- 4,150 克
- 纯度
- 99.0 %
- CAS
- 1005334-57-5
化合物标识与属性
- CAS
- 1005334-57-5
- PubChem CID
- 23661666
- SMILES
- CS(=O)(=O)NC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OCC4=CC(=CC=C4)C(=O)O
- Canonical SMILES
- CS(=O)(=O)Nc1ccc(-c2coc3cc(OCc4cccc(C(=O)O)c4)ccc3c2=O)cc1
名称与同义词
- CVT-10216
- 1005334-57-5
- CVT 10216
- RefChem:128977
- D0W4WP
- UNII-F9H432757X
- YYOOFJZTRCPVFD-UHFFFAOYSA-N
- C24H19NO7S
- orb1308421
- SCHEMBL2107596
- CHEMBL4303226
- F9H432757X
- SCHEMBL29434200
- SCHEMBL30562191
- EX-A311
- GLXC-05699
- BCP27995
- CVT10216
- CVT-10083
- CVT-10200
- CVT-10992
- MFCD18072197
- Undec-5-ynedioic acid dimethyl ester
- ZINC43172134
- 3-(((3-(4-(METHYLSULFONAMIDO)PHENYL)-4-OXO-4H-CHROMEN-7-YL)OXY)METHYL)BENZOIC ACID
- AKOS025142057
- CVT-10216?
- AC-36335
- CID:23661666
- CVT10216; CVT 10216
- DA-48426
- GS455534
- HY-19801
- MS-28573
- 3-(((3-(4-((Methylsulfonyl)amino)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid
- SID:134222422
- CVT-10216 solution, 100 mM in DMSO
- GS 455534
- B4928
- CS-0016659
- FT-0737831
- 3-[[3-[4-(methanesulfonamido)phenyl]-4-oxochromen-7-yl]oxymethyl]benzoic acid
- CVT-10216, >=98% (HPLC)
- ALDH2 antagonists (alcoholism), CV Therapeutics
- 1005334-57-5 solution, 100 mM in DMSO
- A897413
- ALDH2 antagonists (alcoholism), Gilead Palo Alto
- C550386
- Benzoic acid, 3-(((3-(4-((methylsulfonyl)amino)phenyl)-4-oxo-4H-1-benzopyran-7-yl)oxy)methyl)-
- BRD-K60659193-001-01-0
- BRD-K60659193-001-02-8
- Q27277847
- 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]benzoic acid
- 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic Acid
- Aldehyde dehydrogenase-2 antagonists (alcoholism), CV Therapeutics
- 3-((3-(4-(methylsulfonamido)phenyl)-4-oxo-4h-chromen-7-yloxy)methyl)benzoic acid
- 3-({[3-(4-methanesulfonamidophenyl)-4-oxochromen-7-yl]oxy}methyl)benzoic acid
- 3-[(3-{4-[(methylsulfonyl)amino]phenyl}-4-oxochromen-7-yloxy)methyl]benzoic acid
- 3-[[3-[4-(methanesulfonamido)phenyl]-4-oxo-chromen-7-yl]oxymethyl]benzoic acid
- 3-(((3-(4-(methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid solution, 100 mM in DMSO
- 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic Acid; Benzoic acid, 3-[[[3-[4-[(methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]-; 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-1-benzopyran-7-yl]oxy]methyl]benzoic acid; 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)met